A selective 5-HT1a receptor agonist improves respiration in a mouse model of Rett syndrome.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of applied physiology

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/japplphysiol.00889.2013PMID 24092697PMCID PMC3882741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spontaneous inhibitory synaptic currents mediated by a G protein-coupled receptor.

  2013cited by this paper
• Breathing challenges in Rett syndrome: lessons learned from humans and animal models.

  2013cited by this paper
• Systemic Delivery of MeCP2 Rescues Behavioral and Cellular Deficits in Female Mouse Models of Rett Syndrome

  2013cited by this paper
• Electrophysiological and pharmacological properties of GABAergic cells in the dorsal raphe nucleus

  2012cited by this paper
• Use of buspirone and fluoxetine for breathing problems in Rett syndrome.

  2012cited by this paper
• Wild type microglia arrest pathology in a mouse model of Rett syndrome

  2012cited by this paper
• Autonomic dysfunction with mutations in the gene that encodes methyl-CpG-binding protein 2: insights into Rett syndrome.

  2011cited by this paper
• Preferential in vivo action of F15599, a novel 5‐HT1A receptor agonist, at postsynaptic 5‐HT1A receptors

  2010cited by this paper
• Serotonin receptor 1A-modulated phosphorylation of glycine receptor α3 controls breathing in mice.

  2010cited by this paper
• F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.

  2010cited by this paper
• Correction of respiratory disorders in a mouse model of Rett syndrome

  2010cited by this paper
• The potency of different serotonergic agonists in counteracting opioid evoked cardiorespiratory disturbances

  2009cited by this paper
• Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist

  2009cited by this paper
• Serotonin targets inhibitory synapses to induce modulation of network functions

  2009cited by this paper
• 8-OH-DPAT suppresses spontaneous central apneas in the C57BL/6J mouse strain.

  2008cited by this paper
• Spontaneous central apneas occur in the C57BL/6J mouse strain.

  2008cited by this paper
• 5-HT Receptor Regulation of Neurotransmitter Release

  2007cited by this paper
• Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2−/y knockout mice

  2007cited by this paper
• Regional Differences in the Coupling of 5-Hydroxytryptamine-1A Receptors to G Proteins in the Rat Brain

  2006cited by this paper
• Autonomic Nervous System Dysregulation: Breathing and Heart Rate Perturbation During Wakefulness in Young Girls with Rett Syndrome

  2006cited by this paper
• Separate Respiratory Phenotypes in Methyl-CpG-Binding Protein 2 (Mecp2) Deficient Mice

  2006cited by this paper
• Buspirone in Rett syndrome respiratory dysfunction.

  2005cited by this paper
• 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.

  2004cited by this paper
• Serotonin receptors: guardians of stable breathing.

  2003cited by this paper
• Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors.

  2000cited by this paper
• Regulation of central synaptic transmission by 5-HT(1B) auto- and heteroreceptors.

  2000cited by this paper
• A review of central 5-HT receptors and their function.

  1999cited by this paper
• Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

  1999cited by this paper
• Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist.

  1997cited by this paper
• A working heart-brainstem preparation of the mouse.

  1996cited by this paper
• Possible in vivo 5‐HT reuptake blocking properties of 8‐OH‐DPAT assessed by measuring hippocampal extracellular 5‐HT using microdialysis in rats

  1996cited by this paper
• 5‐HT‐1A receptor‐mediated modulation of medullary expiratory neurones in the cat.

  1994cited by this paper
• 5-HT-mediated synaptic potentials in the dorsal raphe nucleus: interactions with excitatory amino acid and GABA neurotransmission.

  1989cited by this paper
• Hyperventilation in the awake state: potentially treatable component of Rett syndrome.

  1988cited by this paper
• Two-sidearm tracheal cannula for respiratory airflow measurements in small animals.

  1983cited by this paper
• Respiratory Physiology & Neurobiology Breathing Disorders in Rett Syndrome: Progressive Neurochemical Dysfunction in the Respiratory Network after Birth

  year unknowncited by this paper

• MECP2 Dysfunction in Rett Syndrome: Molecular Mechanisms, Multisystem Pathology, and Emerging Therapeutic Strategies

  2025cites this paper
• Rescue of respiratory and cognitive impairments in Rett Syndrome mice using NLX-101, a selective 5-HT1A receptor biased agonist.

  2025cites this paper
• Serotonin 5-HT1A receptor biased agonists: the challenge of translating an innovative neuropharmacological concept into therapeutics.

  2024cites this paper
• Serotonin circuits act cooperatively with pathophysiology of opioid use disorder

  2024cites this paper
• Effect of Positive Allosteric Modulation and Orthosteric Agonism of Dopamine D2-like Receptors on Respiration in Mouse Models of Rett Syndrome.

  2024cites this paper
• Drug repurposing in Rett and Rett-like syndromes: a promising yet underrated opportunity?

  2024cites this paper
• Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands

  2024cites this paper
• The Efficacy of Noninvasive Ventilation in Patients Affected by Rett Syndrome With Hypoventilation.

  2024cites this paper
• Impact of Serotonergic 5HT1A and 5HT2A Receptor Activation on the Respiratory Response to Hypercapnia in a Rat Model of Parkinson’s Disease

  2024cites this paper
• Revisiting the Role of Serotonin in Sleep-Disordered Breathing

  2024cites this paper
• Molecular Mechanisms of Rett Syndrome: Emphasizing the Roles of Monoamine, Immunity, and Mitochondrial Dysfunction

  2024cites this paper
• The role of Kölliker-Fuse nucleus in breathing variability

  2023cites this paper
• Exploring the role of the Kölliker–Fuse nucleus in breathing variability by mathematical modelling

  2023cites this paper
• Inhibitory synaptic transmission is impaired in the Kölliker-Fuse of male, but not female, Rett Syndrome Mice

  2023cites this paper
• A narrative review of the mechanisms and consequences of intermittent hypoxia and the role of advanced analytic techniques in pediatric autonomic disorders

  2023cites this paper
• Breathing disturbances in Rett syndrome.

  2022cites this paper
• 5-HT1A Receptor Agonist Treatment Partially Ameliorates Rett Syndrome Phenotypes in mecp2-Null Mice by Rescuing Impairment of Neuron Transmission and the CREB/BDNF Signaling Pathway

  2022cites this paper
• Effect of Positive Allosteric Modulation and Orthosteric Agonism of Dopamine D2 Receptors on Respiration in Mouse Models of Rett Syndrome

  2022cites this paper
• Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?

  2021cites this paper
• Fluoxetine increases brain MeCP2 immuno-positive cells in a female Mecp2 heterozygous mouse model of Rett syndrome through endogenous serotonin

  2021cites this paper
• Aberrant lung lipids cause respiratory impairment in a Mecp2-deficient mouse model of Rett syndrome

  2021cites this paper
• Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders.

  2021cites this paper
• Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor

  2021influential citation
• Drug Studies on Rett Syndrome: From Bench to Bedside

  2020cites this paper
• Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder.

  2020cites this paper
• Morphine‐induced respiratory depression is independent of β‐arrestin2 signalling

  2020cites this paper
• Neurochemistry of the Kölliker‐Fuse nucleus from a respiratory perspective

  2020cites this paper
• The antitussive cloperastine improves breathing abnormalities in a Rett Syndrome mouse model by blocking presynaptic GIRK channels and enhancing GABA release.

  2020cites this paper
• Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects

  2019cites this paper
• Ketamine promotes rapid and transient activation of AMPA receptor‐mediated synaptic transmission in the dorsal raphe nucleus

  2019cites this paper
• Pharmacological MRI to investigate the functional selectivity of 5-HT1A receptor biased agonists.

  2019cites this paper
• Differential impact of two critical respiratory centres in opioid‐induced respiratory depression in awake mice

  2019cites this paper
• Reduced computational modelling of Kölliker‐Fuse contributions to breathing patterns in Rett syndrome

  2019influential citation
• Treating Rett syndrome: from mouse models to human therapies

  2019cites this paper
• Cellular And Molecular Insight Into Autonomic Function And Dysfunction

  2018cites this paper
• Functional selectivity – chance for better and safer drugs?

  2017cites this paper
• Inactivation of GIRK channels weakens the pre‐ and postsynaptic inhibitory activity in dorsal raphe neurons

  2017cites this paper
• Breathing abnormalities in animal models of Rett syndrome a female neurogenetic disorder.

  2017cites this paper
• INTERVENTION TO EXTRASYNAPTIC GABAA RECEPTORS FOR SYMPTOM RELIEF IN MOUSE MODELS OF RETT SYNDROME

  2017cites this paper
• The Journal of Clinical Investigation

  2016cites this paper
• Mechanisms of 5‐HT1A receptor‐mediated transmission in dorsal raphe serotonin neurons

  2016cites this paper
• Mechanisms of Autoreceptor-Mediated Inhibition in Central Monoamine Neurons

  2016cites this paper
• 5-Hydroxy-tryptamine (5HT)-Related Therapy in Neurological Diseases

  2016cites this paper
• Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study

  2016cites this paper
• Breathing abnormalities in a female mouse model of Rett syndrome

  2015cites this paper
• 5-HT1A Receptor Agonist Befiradol Reduces Fentanyl-induced Respiratory Depression, Analgesia, and Sedation in Rats

  2015cites this paper
• The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autism.

  2015cites this paper
• MECP2 disorders: from the clinic to mice and back.

  2015cites this paper
• Analysis of the method for ventilation heterogeneity assessment using the Otis model and forced oscillations

  2015cites this paper
• Optogenetic Approaches to Restoring Vision.

  2015cites this paper
• Characterization of the MeCP2R168X Knockin Mouse Model for Rett Syndrome

  2014cites this paper
• Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists

  2014cites this paper
• Fresh from the designation pipeline: orphan drugs recently designated in the European Union (December 2013-February 2014)

  2013cites this paper